The novel product of a five-exon stargazin-related gene abolishes Cav2.2 calcium channel expression

被引:67
|
作者
Moss, FJ
Viard, P
Davies, A
Bertaso, F
Page, KM
Graham, A
Cantí, C
Plumpton, M
Plumpton, C
Clare, JJ
Dolphin, AC
机构
[1] UCL, Dept Pharmacol, London WC1E 6BT, England
[2] GlaxoSmithKline, Med Res Ctr, Bioinformat Unit, Stevenage SG1 2NY, Herts, England
[3] GlaxoSmithKline, Med Res Ctr, Gene Express & Prot Biochem, Stevenage SG1 2NY, Herts, England
来源
EMBO JOURNAL | 2002年 / 21卷 / 07期
关键词
calcium channel; expression; gamma subunit; stargazin; suppression;
D O I
10.1093/emboj/21.7.1514
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have cloned and characterized a new member of the voltage-dependent Ca2+ channel gamma subunit family, with a novel gene structure and striking properties. Unlike the genes of other potential gamma subunits identified by their homology to the stargazin gene, CACNG7 is a five-, and not four-exon gene whose mRNA encodes a protein we have designated gamma(7). Expression of human gamma(7) has been localized specifically to brain. N-type current through Ca(V)2.2 channels was almost abolished when co-expressed transiently with gamma(7) in either Xenopus oocytes or COS-7 cells. Furthermore, immunocytochemistry and western blots show that gamma(7) has this effect by causing a large reduction in expression of Ca(V)2.2 rather than by interfering with trafficking or biophysical properties of the channel. No effect of transiently expressed gamma(7) was observed on pre-existing endogenous N-type calcium channels in sympathetic neurones. Low homology to the stargazin-like gamma subunits, different gene structure and the unique functional properties of gamma(7) imply that it represents a distinct subdivision of the family of proteins identified by their structural and sequence homology to stargazin.
引用
收藏
页码:1514 / 1523
页数:10
相关论文
共 5 条
  • [1] The Stargazin-Related Protein γ7 Interacts with the mRNA-Binding Protein Heterogeneous Nuclear Ribonucleoprotein A2 and Regulates the Stability of Specific mRNAs, Including CaV2.2
    Ferron, Laurent
    Davies, Anthony
    Page, Karen M.
    Cox, David J.
    Leroy, Jerome
    Waithe, Dominic
    Butcher, Adrian J.
    Sellaturay, Priya
    Bolsover, Steven
    Pratt, Wendy S.
    Moss, Fraser J.
    Dolphin, Annette C.
    JOURNAL OF NEUROSCIENCE, 2008, 28 (42): : 10604 - 10617
  • [2] Development of High Throughput Calcium Channel Assays to Accelerate the Discovery of Novel Toxins Targeting Human Cav2.2 Channels
    Sousa, Silmara R.
    Ragnarsson, Lotten
    Vetter, Irina
    Herzig, Volker
    King, Glenn F.
    Lewis, Richard J.
    TOXICON, 2012, 60 (02) : 111 - 111
  • [3] Identification and characterization of novel human Cav2.2 (α1B) calcium channel variants lacking the synaptic protein interaction site
    Kaneko, S
    Cooper, CB
    Nishioka, N
    Yamasaki, H
    Suzuki, A
    Jarvis, SE
    Akaike, A
    Satoh, M
    Zamponi, GW
    JOURNAL OF NEUROSCIENCE, 2002, 22 (01): : 82 - 92
  • [4] ZC88, a novel N-type calcium channel blocker from 4-amino-piperidine derivatives state-dependent inhibits Cav2.2 calcium channels
    Zhang, Shuzhuo
    Yang, Lujia
    Zhang, Kang
    Liu, Xiaoyan
    Dai, Weiwei
    Zhang, Cheng
    Yong, Zheng
    Li, Jin
    Zheng, Jianquan
    BRAIN RESEARCH, 2015, 1605 : 12 - 21
  • [5] Novel Mechanism of Voltage-Gated N-type (Cav2.2) Calcium Channel Inhibition Revealed through α-Conotoxin Vc1.1 Activation of the GABAB Receptor
    Huynh, Thuan G.
    Cuny, Hartmut
    Slesinger, Paul A.
    Adams, David J.
    MOLECULAR PHARMACOLOGY, 2015, 87 (02) : 240 - 250